Search - tctmd.com

Displaying 141 - 160 of 176

Sort: Relevancy | Date

Presentation ICI 2012

Initial Clinical Experience with Turbo Hawk Calcium Cutter Atherectomy Device

Presenter: A. Schmidt

December 02, 2012

News Industry News

Edwards Lifesciences Receives Approval for PERIMOUNT Mitral Heart Valve in China

November 27, 2012

Presentation TCT 2012

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

Presenter: Szilard Voros

October 23, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Predictors of Aortic Regurgitation After TAVR Delineated

August 26, 2012

News Daily News

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

Jason Kahn

June 18, 2012

News Daily News

CTA Not Justified to Risk Stratify Patients Without Chest Pain

L.A. McKeown

June 18, 2012

News Daily News

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

Yael L. Maxwell

June 08, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Conference News ACC 2012

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

March 25, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

News Daily News

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

March 23, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Yael L. Maxwell

March 07, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Daily News

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

Jason Kahn

February 12, 2012

Presentation

Is There a Clinically Significant Interaction Between Calcium Channel Antagonists and Clopidogrel?

Presenter: Christopher W. Good

February 12, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

Presentation TCT 2012

Six-Month Outcomes of Prospective, Randomized CALCIUM 360 Study Demonstrate the Advantages of Plaque Modification with the Orbital Technology Versus Treatment with Balloon...

Presenter: Nicolas W. Shammas, Jihad Mustapha, Russell Lam, Jonathan Ellichman, Gaurav Aggarwala, Khusrow Niazi, Nilesh Balar

January 03, 2012

Advertisement

Initial Clinical Experience with Turbo Hawk Calcium Cutter Atherectomy Device

Edwards Lifesciences Receives Approval for PERIMOUNT Mitral Heart Valve in China

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

FDA expands approved use of Sapien artificial heart valve

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Predictors of Aortic Regurgitation After TAVR Delineated

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

CTA Not Justified to Risk Stratify Patients Without Chest Pain

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

Better Clopidogrel Response Seen with Increased Smoking Levels

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

Is There a Clinically Significant Interaction Between Calcium Channel Antagonists and Clopidogrel?

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Six-Month Outcomes of Prospective, Randomized CALCIUM 360 Study Demonstrate the Advantages of Plaque Modification with the Orbital Technology Versus Treatment with Balloon...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content